[Clindamycin-2-phosphate and surgical infections (author's transl)]. 1977

H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami

Blood levels of clindamycin-2-phosphate in dog at dosis of 10 mg/kg body weight showed the maximum of 21 mug/ml 30 seconds after one-shot i.v. administration. Continuous infusion of the antibiotic at the infusion speed of 150 and 300 ml/hour/10 kg b.w. with 6 mg/ml solution maintained blood levels of 30 and 170 mug/ml respectively. It may be recommended clinically to use lower concentration than 6 mg/ml to avoid cardiocirculatory disturbances. Four cases of surgical mixed infections with gram-positive cocci, gram-negative bacilli and anaerobes were treated with clindamycin-2-phosphate at a daily dosis of 1,200 mg intravenously and 2 of 4 cases revealed good clinical response. There was none of the haematological, hepatic, nephrontic, cardiocirculatory and allergic side effects.

UI MeSH Term Description Entries
D008100 Liver Abscess Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents. Abscess, Hepatic,Abscess, Liver,Abscesses, Hepatic,Abscesses, Liver,Hepatic Abscess,Hepatic Abscesses,Liver Abscesses
D008297 Male Males
D008477 Mediastinal Diseases Disorders of the mediastinum, general or unspecified. Disease, Mediastinal,Diseases, Mediastinal,Mediastinal Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D012002 Rectal Diseases Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE). Anorectal Diseases,Anorectal Disorders,Rectal Disorders,Anorectal Disease,Anorectal Disorder,Rectal Disease,Rectal Disorder
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
May 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
February 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
February 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
January 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
March 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
January 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
January 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
February 1974, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
January 1977, The Japanese journal of antibiotics,
H Ishibiki, and N Murayama, and Y Hosoda, and K Katsumoto, and H Takami
March 1977, The Japanese journal of antibiotics,
Copied contents to your clipboard!